Partelli, SMassironi, SZerbi, ANiccoli, PKwon, WLandoni, LPanzuto, FTomazic, ABongiovanni, AKaltsas, GSauvanet, ABertani, EMazzaferro, VCaplin, MArmstrong, TWeickert, MRamage, JSegelov, EButturini, GStaettner, SCives, MFrilling, AMoulton, CHe, JBoesch, FSelberheer, ATwito, OCastaldi, ADe Angelis, CGaujoux, SHolzer, KWilson, CAlmeamar, HVigia, EMuffatti, FLucà, MLania, AEwald, JKim, HSalvia, RRinzivillo, MSmid, AGardini, ATsoli, MHentic, OColombo, SCitterio, DToumpanakis, CRamsey, ERandeva, HSrirajaskanthan, RCroagh, DRegi, PGasteiger, SInvernizzi, PRidolfi, CGiovannini, MJang, JYBassi, CFalconi, M2023-12-052023-12-052022-11Br J Surg . 2022 Nov 22;109(12):1186-1190.http://hdl.handle.net/10400.17/4756engHCC CHBPTHumansNeuroendocrine Tumors* / surgeryPancreatectomyPancreatic Neoplasms* / surgeryProspective StudiesManagement of Asymptomatic Sporadic Non-Functioning Pancreatic Neuroendocrine Neoplasms No Larger Than 2 Cm: Interim Analysis of Prospective ASPEN Trialjournal article10.1093/bjs/znac267